A large number of clinical trials showed that candesartan could reduce the cardiovascular mortality for heart failure and hospitalization for worsening heart failure.

• 大量临床研究结果表明坎地沙坦可降低心力衰竭病人心血管死亡率和因心力衰竭加重的住院率。